Loading clinical trials...
Loading clinical trials...
This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will be conducted: one for...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Edinburgh
NCT02593565 · Vasculitis, Behcet's Disease, and more
NCT06887062 · Large Vessel Vasculitis, Giant Cell Arteritis (GCA), and more
NCT07184814 · Takayasu Arteritis With Pulmonary Artery Involvement, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
NCT06498089 · Takayasu Arteritis
NCT05388682 · Takayasu Arteritis With Pulmonary Artery Involvement, Percutaneous Transluminal Pulmonary Angioplasty, and more
University of Edinburgh
Edinburgh
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions